While implementation of PSMA-PET led to relevant improvements in disease localization, with results of prospective trials pending, it is not yet clear whether the sole spatial information of tumor burden and the accompanying changes in treatment management have a relevant impact on progression rates. Here, FOLH1 is linked to neoplasm.